HMGB1 and serum lipopolysaccharide activity: There are many studies showing a promising protective effect by blocking HMGB1 in experimental models of several inflammatory diseases, including endotoxemia, arthritis and ischaemia–reperfusion injury 47, 48, 49, 50, 51.